Peter Rubin
Impact in
- Immunology top 5%
- Immune Cell Function and Interaction
- Reproductive System and Pregnancy
- T-cell and B-cell Immunology
- Genetics top 2%
- Inflammatory Bowel Disease
Papers in
- Co-authors
- Daniel H. Present (9 shared papers)Hugh F. Pross (7 shared papers)Malcolm G. Baines (3 shared papers)Peter C. Shragge (1 shared paper)Michael S. Patterson (1 shared paper)Carol Bodian (5 shared papers)Sonia Friedman (4 shared papers)Noam Harpaz (6 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Gastroenterology (4 papers)Cancer Research (4 papers)Inflammatory Bowel Diseases (3 papers)Cancer Chemotherapy and Pharmacology (2 papers)
- Partner nations
- United StatesCanadaSouth Africa
In The Last Decade
Peter Rubin
62 papers receiving 2.5k citations
Peter Rubin's Hit Papers
Peers
Comparison fields: 5 of 111
- Immunology 826
- Genetics 867
- Oncology 678
- Epidemiology 621
- Gastroenterology 83
Countries citing papers authored by Peter Rubin
This map shows the geographic impact of Peter Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Rubin more than expected).
Fields of papers citing papers by Peter Rubin
This network shows the impact of papers produced by Peter Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Rubin. The network helps show where Peter Rubin may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Rubin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 65 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantitation of natural killer cell activity Hit paper breakdown → | 1981 | 644 |
| 2 | 1999 | 235 | |
| 3 | 2003 | 217 | |
| 4 | 2001 | 181 | |
| 5 | 2004 | 127 | |
| 6 | 1991 | 108 | |
| 7 | 2017 | 70 | |
| 8 | 2008 | 66 | |
| 9 | 1998 | 62 | |
| 10 | 1995 | 55 | |
| 11 | 1982 | 49 | |
| 12 | 2001 | 49 | |
| 13 | 1999 | 49 | |
| 14 | A comparison of mesalamine suspension enema and oral sulfasalazine for treatment of active distal ulcerative colitis in adults. | 1996 | 45 |
| 15 | 1995 | 44 | |
| 16 | 2008 | 41 | |
| 17 | Phase II study of the safety and efficacy of a 5-lipoxygenase inhibitor in patients with ulcerative colitis. | 1992 | 40 |
| 18 | 1993 | 36 | |
| 19 | 1988 | 31 | |
| 20 | 2007 | 30 |
About Peter Rubin
Peter Rubin is a scholar working on Oncology, Genetics, Pulmonary and Respiratory Medicine, Surgery and Immunology, having authored 65 papers that have together received 2.6k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (12 papers), Inflammatory Bowel Disease (11 papers), HER2/EGFR in Cancer Research (7 papers), Immune Cell Function and Interaction (6 papers), Estrogen and related hormone effects (6 papers), Colorectal Cancer Screening and Detection (6 papers), Microscopic Colitis (5 papers) and Hematopoietic Stem Cell Transplantation (5 papers). The work is most often cited by research in Immunology (826 citations), Genetics (867 citations), Oncology (678 citations), Epidemiology (621 citations) and Gastroenterology (83 citations). Peter Rubin has collaborated with scholars based in United States, Canada and South Africa. Frequent co-authors include Daniel H. Present, Hugh F. Pross, Malcolm G. Baines, Peter C. Shragge, Michael S. Patterson, Carol Bodian, Sonia Friedman, Noam Harpaz, Mark L. Chapman and Eric S. Goldstein. Their work appears in journals such as Journal of Clinical Oncology, Gastroenterology, Cancer Research, Inflammatory Bowel Diseases and Cancer Chemotherapy and Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.